English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The study was performed to investigate the immunogenicity of Salmonella and Fowl cholera vaccine prepared at BAU using Shuvra strain of chickens administered with BAU Salmonella bivalent and BAU Fowl cholera vaccines prepared by “Livestock and Poultry VaccineResearch and Production Centre”, (LPVRPC). A total of 60 apparently healthy BLRI strains Shuvra were used in this study. The birds were divided into three groups, consisting of 20 birds in each group. Shuvra- A group birds were vaccinated with BAU Salmonella bivalentvaccine, Shuvra-B group birds with BAU Fowl cholera vaccines and Shuvra-C group birds were used as unvaccinated control. The birds, except the ones in group C, were vaccinated intramuscularly (0.5ml) at 8 weeks of age followed by a booster dose at 12 weeks of age.Sera samples were collected on day 56, 85, 105 days and after challenge at 140 days age of birds. Secondary (booster) vaccination (P< 0.05) exhibited a significant level of antibody response. The antibody titre of these birds slowly descended till four weeks of challenge test. It was observed that a dependable level of immunogenicity of BAU Salmonella Bivalent and BAU Fowl cholera vaccine was observed when administered under this schedule followed inShuvra strain of chickens

Immunogenicity of BAU-Bivalent Salmonella and Fowl Cholera Vaccines in Shuvra Chickens